Cargando…

Prevalence and risk factors associated with lymphatic filariasis in American Samoa after mass drug administration

BACKGROUND: In 2000, American Samoa had 16.5% prevalence of lymphatic filariasis (LF) antigenemia. Annual mass drug administration (MDA) was conducted using single-dose albendazole plus diethylcarbamazine from 2000 to 2006. This study presents the results of a 2007 population-based PacELF C-survey i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Coutts, Shaun P., King, Jonathan D., Pa’au, Molisamoa, Fuimaono, Saipale, Roth, Joseph, King, Mary Rose, Lammie, Patrick J., Lau, Colleen L., Graves, Patricia M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5543440/ https://www.ncbi.nlm.nih.gov/pubmed/28794687 http://dx.doi.org/10.1186/s41182-017-0063-8

Ejemplares similares

Seroprevalence and Spatial Epidemiology of Lymphatic Filariasis in American Samoa after Successful Mass Drug Administration
por: Lau, Colleen L., et al.
Publicado: (2014)

Comparison of Immunochromatographic Test (ICT) and Filariasis Test Strip (FTS) for Detecting Lymphatic Filariasis Antigen in American Samoa, 2016
por: Sheel, Meru, et al.
Publicado: (2021)

Demographic, socioeconomic and disease knowledge factors, but not population mobility, associated with lymphatic filariasis infection in adult workers in American Samoa in 2014
por: Graves, Patricia M., et al.
Publicado: (2020)

Lymphatic filariasis in 2016 in American Samoa: Identifying clustering and hotspots using non-spatial and three spatial analytical methods
por: Wangdi, Kinley, et al.
Publicado: (2022)

Detecting and confirming residual hotspots of lymphatic filariasis transmission in American Samoa 8 years after stopping mass drug administration
por: Lau, Colleen L., et al.
Publicado: (2017)

Spatial predictive risk mapping of lymphatic filariasis residual hotspots in American Samoa using demographic and environmental factors
por: Cadavid Restrepo, Angela M., et al.
Publicado: (2023)

Identifying residual transmission of lymphatic filariasis after mass drug administration: Comparing school-based versus community-based surveillance - American Samoa, 2016
por: Sheel, Meru, et al.
Publicado: (2018)

Comparison of antigen and antibody responses in repeat lymphatic filariasis transmission assessment surveys in American Samoa
por: Won, Kimberly Y., et al.
Publicado: (2018)

Potential use of antibodies to provide an earlier indication of lymphatic filariasis resurgence in post–mass drug ad ministration surveillance in American Samoa
por: Cadavid Restrepo, Angela M., et al.
Publicado: (2022)

Lymphatic Filariasis Elimination in American Samoa: Evaluation of Molecular Xenomonitoring as a Surveillance Tool in the Endgame
por: Lau, Colleen L., et al.
Publicado: (2016)

Potential strategies for strengthening surveillance of lymphatic filariasis in American Samoa after mass drug administration: Reducing ‘number needed to test’ by targeting older age groups, hotspots, and household members of infected persons
por: Lau, Colleen L., et al.
Publicado: (2020)

Triple-Drug Treatment Is Effective for Lymphatic Filariasis Microfilaria Clearance in Samoa
por: Graves, Patricia M., et al.
Publicado: (2021)

Lymphatic filariasis endgame strategies: Using GEOFIL to model mass drug administration and targeted surveillance and treatment strategies in American Samoa
por: Shaw, Callum, et al.
Publicado: (2023)

Molecular Xenomonitoring Using Mosquitoes to Map Lymphatic Filariasis after Mass Drug Administration in American Samoa
por: Schmaedick, Mark A., et al.
Publicado: (2014)

Spatially Explicit Environmental Factors Associated with Lymphatic Filariasis Infection in American Samoa
por: Lemin, Morgan E., et al.
Publicado: (2022)

Scabies prevalence after ivermectin-based mass drug administration for lymphatic filariasis, Samoa 2018–2019
por: Willis, Gabriela A., et al.
Publicado: (2023)

Evaluating Molecular Xenomonitoring as a Tool for Lymphatic Filariasis Surveillance in Samoa, 2018–2019
por: McPherson, Brady, et al.
Publicado: (2022)

Supporting elimination of lymphatic filariasis in Samoa by predicting locations of residual infection using machine learning and geostatistics
por: Mayfield, Helen J., et al.
Publicado: (2020)

Lymphatic filariasis epidemiology in Samoa in 2018: Geographic clustering and higher antigen prevalence in older age groups
por: Lau, Colleen L., et al.
Publicado: (2020)

A community survey of coverage and adverse events following country-wide triple-drug mass drug administration for lymphatic filariasis elimination, Samoa 2018
por: Willis, Gabriela A., et al.
Publicado: (2020)

Burden of hydrocoele assessed from medical and surgical records in a lymphatic filariasis endemic country, Samoa
por: Ah Leong-Lui, Tile A., et al.
Publicado: (2019)

Leptospirosis, American Samoa
por: Lau, Colleen L., et al.
Publicado: (2012)

Cost-effectiveness analysis of a cluster-randomized, culturally tailored, community health worker home-visiting diabetes intervention versus standard care in American Samoa
por: Huang, Shuo J., et al.
Publicado: (2019)

Development and Introduction of the Filariasis Test Strip: A New Diagnostic Test for the Global Program to Eliminate Lymphatic Filariasis
por: Pantelias, Anastasia, et al.
Publicado: (2022)

Global Programme to Eliminate Lymphatic Filariasis: The Processes Underlying Programme Success
por: Ichimori, Kazuyo, et al.
Publicado: (2014)

Notes from the Field: Impact of a Mass Drug Administration Campaign Using a Novel Three-Drug Regimen on Lymphatic Filariasis Antigenemia — American Samoa, 2019
por: Hast, Marisa A., et al.
Publicado: (2020)

Seroprevalence of Dengue in American Samoa, 2010
por: Duncombe, Jennifer, et al.
Publicado: (2013)

A Synthetic Population for Modelling the Dynamics of Infectious Disease Transmission in American Samoa
por: Xu, Zhijing, et al.
Publicado: (2017)

Mass Drug Administration for the Elimination of Lymphatic Filariasis — Port-au-Prince, Haiti, 2011–2012
por: Streit, Thomas, et al.
Publicado: (2013)

Endpoints for Lymphatic Filariasis Programs
por: Grady, Caroline A., et al.
Publicado: (2007)

Impact of Ivermectin Mass Drug Administration for Lymphatic Filariasis on Scabies in Eight Villages in Kongwa District, Tanzania
por: Martin, Diana, et al.
Publicado: (2018)

The extensive networks of frequent population mobility in the Samoan Islands and their implications for infectious disease transmission
por: Xu, Zhijing, et al.
Publicado: (2018)

The Global Programme to Eliminate Lymphatic Filariasis: History and achievements with special reference to annual single-dose treatment with diethylcarbamazine in Samoa and Fiji
por: Kimura, Eisaku
Publicado: (2011)

Evolution of the monitoring and evaluation strategies to support the World Health Organization's Global Programme to Eliminate Lymphatic Filariasis
por: Lammie, Patrick J, et al.
Publicado: (2020)

Population pharmacokinetic model of ivermectin in mass drug administration against lymphatic filariasis
por: Alshehri, Abdullah, et al.
Publicado: (2023)

Emergence of new leptospiral serovars in American Samoa - ascertainment or ecological change?
por: Lau, Colleen L, et al.
Publicado: (2012)

Leptospirosis in American Samoa – Estimating and Mapping Risk Using Environmental Data
por: Lau, Colleen L., et al.
Publicado: (2012)

Translating Research into Reality: Elimination of Lymphatic Filariasis from Haiti
por: Lammie, Patrick J., et al.
Publicado: (2017)

Impact of the Lymphatic Filariasis Control Program towards elimination of filariasis in Vanuatu, 1997–2006
por: Allen, Tammy, et al.
Publicado: (2017)

Overview of PacELF—the Pacific Programme for the Elimination of Lymphatic Filariasis
por: Ichimori, Kazuyo, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_fdn8bb1entdfqne98mgnns67bf